Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

TC BioPharm (Holdings) plc - American Depositary Shares (NQ:TCBP)

0.5000 UNCHANGED
Last Price Updated: 4:00 PM EDT, Mar 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about TC BioPharm (Holdings) plc - American Depositary Shares

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Top movers in Monday's after hours session
As the regular session of the US market on Monday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment. 
Via Chartmill
Regencell, GlucoTrack, TC Biopharm, AbbVie, Actinium: 5 Health Care Stocks That Lit Up Retail Discussions Last Week
Investors reacted to insider buying, clinical trial updates, and strategic business shifts that happened in the week ended March 21, 2025. 
Via Stocktwits
Curious about the stocks that are showing activity after the closing bell on Friday?
Let's have a look at what is happening on the US markets after the closing bell on Friday. Below you can find the top gainers and losers in today's after hours session. 
Via Chartmill
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Top stock movements in today's session.
Wondering how the US markets performed one hour before the close of the markets on Friday? Discover the movers and shakers of today's session in our comprehensive analysis. 
Via Chartmill
Here are the top movers in Friday's session.
Wondering how the US markets performed in the middle of the day on Friday? Discover the movers and shakers of today's session in our comprehensive analysis. 
Via Chartmill
TC BioPharm Stock Crashes On Nasdaq Delisting: Retail Expresses Frustration
TC BioPharm said its securities will be suspended for trading on the exchange beginning Monday. 
Via Stocktwits
Why TC Biopharm (TCBP) Stock Is Down Over 60% Today
TC Biopharm shares are trading lower by 64% during Friday's session. The company announced the transition from Nasdaq to OTC markets. 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Which stocks are gapping on Friday?
Let's have a look at what is happening on the US markets on Friday. Below you can find the gap up and gap down stocks in today's session. 
Via Chartmill
BioMedNewsBreaks — TC BioPharm Holdings PLC (NASDAQ: TCBP) to Be Delisted, Will Move to OTC Markets
Via Investor Brand Network
InvestorNewsBreaks – TC BioPharm Holdings PLC (NASDAQ: TCBP) Restructures Operations to Enhance Efficiency and Reduce Costs
Via Investor Brand Network
BioMedNewsBreaks — TC BioPharm Holdings PLC (NASDAQ: TCBP) Signs Letter of Intent to Acquire Ophthalmic Pharma Company
Via Investor Brand Network
InvestorNewsBreaks – TC BioPharm Holdings PLC (NASDAQ: TCBP) CEO to Speak at European Life Sciences CEO Forum
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
InvestorNewsBreaks – TC BioPharm Holdings PLC (NASDAQ: TCBP) Completes Dosing in Phase 2B AML Trial, Reports Positive Early Data
Via Investor Brand Network
Which stocks are experiencing notable movement on Monday?
Curious to know what's happening on the US markets one hour before the close of the markets on Monday? Join us as we explore the top gainers and losers in today's session. 
Via Chartmill
Let's have a look at the top gainers and losers in the middle of the day of today's session.
Keep an eye on the top gainers and losers in Monday's session, as they reflect the most notable price movements. 
Via Chartmill
InvestorNewsBreaks – TC BioPharm Holdings PLC (NASDAQ: TCBP) Advances ACHIEVE Trial With Completion of First Cohort B Dosing
Via Investor Brand Network
The market is filled with gapping stocks in Monday's session.
Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Monday. Let's explore the market movements and identify the stocks with significant gaps. 
Via Chartmill
EXCLUSIVE: Nano-Cap TC BioPharm Concludes Initial Cohort B Patient Dosing In Mid-Stage Leukemia Trial, Data Readout By End Of 2025
TC BioPharm's Phase 2B trial of TCB008 in AML progresses as the first Cohort B patient completes dosing. Enrollment continues, with data expected in 2025. 
Via Benzinga
InvestorNewsBreaks – TC BioPharm Holdings PLC (NASDAQ: TCBP) Announces ADS Ratio Change Effective Feb. 10
Via Investor Brand Network
Here are the top movers in Wednesday's session.
Curious about what's happening in today's session? Check out the latest stock movements and price changes. 
Via Chartmill
InvestorNewsBreaks – TC BioPharm Holdings PLC (NASDAQ: TCBP) Advances Preclinical Studies for Bird Flu Treatment with TCB008
Via Investor Brand Network
BioMedNewsBreaks — TC BioPharm Holdings PLC (NASDAQ: TCBP) to Present at Sequire Investor Summit 2025
Via Investor Brand Network
BioMedNewsBreaks — TC BioPharm Holdings PLC (NASDAQ: TCBP) Confirms Continued Nasdaq Trading Under TCBP
Via Investor Brand Network
InvestorNewsBreaks – TC BioPharm Holdings PLC (NASDAQ: TCBP) Shareholders Approve 25% Stock Dividend
Via Investor Brand Network
BioMedNewsBreaks — TC BioPharm Holdings PLC (NASDAQ: TCBP) Reports Positive Safety Data in ACHIEVE Phase 2b Trial for AML and MDS/AML
Via Investor Brand Network
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
BioMedNewsBreaks — TC BioPharm Holdings PLC (NASDAQ: TCBP) Announces Special Dividend for Shareholders Amid Ongoing Support
Via Investor Brand Network
Topics Regulatory Compliance
Exposures Legal Regulatory
EXCLUSIVE: Penny Stock TC BioPharm Proposes Special Stock Dividend
TC BioPharm to issue a special dividend of 0.25 ADS per share, pending shareholder approval at the December 30 meeting. Record date: January 2, 2025. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.